Literature DB >> 12966671

Unrelated donor stem cell transplantation: the role of the National Marrow Donor Program.

Chatchada Karanes1, Dennis Confer, Tim Walker, Andrea Askren, Claire Keller.   

Abstract

Since its founding in 1986, the NMDP has facilitated more than 16,000 transplants for patients with blood disorders such as leukemia and aplastic anemia, as well as immune system disorders and genetic disorders. The donors who provided the blood stem cells for these transplants came from the NMDP Registry, the world's largest and most diverse registry of potential blood stem cell donors. Initiating a search of the NMDP Registry for an HLA-matched unrelated donor is as simple as submitting to the NMDP a patient's HLA typing results along with basic demographic and disease information. If a suitable donor is identified, the NMDP coordinates the steps needed to bring the donated stem cells--whether they be marrow, PBSC, or cord blood--to a patient. After reading this article, physicians should have a greater understanding of the complicated process needed to bring about an unrelated donor stem cell transplant. A better understanding of the role the NMDP plays in unrelated donor stem cell transplantation reduces the chances that physicians and patients will have unrealistic expectations about the process. To initiate a preliminary search of the NMDP Registry, contact the NMDP Office of Patient Advocacy toll-free at 1-888-999-6743. A preliminary search reqest form can also be submitted via the NMDP website:www.marrow.org

Entities:  

Mesh:

Year:  2003        PMID: 12966671

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  5 in total

1.  Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose.

Authors:  Michael A Pulsipher; Pintip Chitphakdithai; Brent R Logan; Susan F Leitman; Paolo Anderlini; John P Klein; Mary M Horowitz; John P Miller; Roberta J King; Dennis L Confer
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

Review 2.  The rationale behind collecting umbilical cord blood.

Authors:  Nicolas H Zech; Nikolas Broer; Iris Ribitsch; Mathias H Zech; Karl-Heinz Broer; Kubilay Ertan; Karl-Heinz Preisegger
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-06-01

3.  Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant.

Authors:  Hillard M Lazarus; Fangyu Kan; Sergey Tarima; Richard E Champlin; Dennis L Confer; Noelle Frey; Adrian P Gee; John E Wagner; Mary M Horowitz; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2009-05       Impact factor: 5.742

Review 4.  The HLA system: genetics, immunology, clinical testing, and clinical implications.

Authors:  Sung Yoon Choo
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

Review 5.  Umbilical cord blood quality and quantity: Collection up to transplantation.

Authors:  Seyed Hadi Mousavi; Morteza Zarrabi; Saeid Abroun; Mona Ahmadipanah; Bahareh Abbaspanah
Journal:  Asian J Transfus Sci       Date:  2019-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.